Amit Gupta - Cardlytics CEO Director
| CDLX Stock | USD 1.88 0.37 24.50% |
CEO
Amit Gupta is CEO Director of Cardlytics
| Age | 51 |
| Phone | 888 798 5802 |
| Web | https://www.cardlytics.com |
Amit Gupta Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amit Gupta against Cardlytics stock is an integral part of due diligence when investing in Cardlytics. Amit Gupta insider activity provides valuable insight into whether Cardlytics is net buyers or sellers over its current business cycle. Note, Cardlytics insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cardlytics'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amit Gupta over three months ago Acquisition by Amit Gupta of 500000 shares of Cardlytics subject to Rule 16b-3 | ||
Amit Gupta over three months ago Disposition of 15160 shares by Amit Gupta of Cardlytics at 3.92 subject to Rule 16b-3 | ||
Amit Gupta over three months ago Disposition of 43750 shares by Amit Gupta of Cardlytics subject to Rule 16b-3 | ||
Amit Gupta over three months ago Disposition of 5964 shares by Amit Gupta of Cardlytics at 3.667 subject to Rule 16b-3 |
Cardlytics Management Efficiency
The company has return on total asset (ROA) of (0.0878) % which means that it has lost $0.0878 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.3548) %, meaning that it created substantial loss on money invested by shareholders. Cardlytics' management efficiency ratios could be used to measure how well Cardlytics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 11 records | CEO Age | ||
| Herve Sedky | Emerald Expositions Events | 55 | |
| Jonathan Nelson | Omnicom Group | 57 | |
| Amy Armstrong | Interpublic Group of | N/A | |
| Adam Peterson | Boston Omaha Corp | 44 | |
| David Peacock | Advantage Solutions | 57 | |
| Michael Komasinski | Criteo Sa | 54 | |
| Alexander Rozek | Boston Omaha Corp | 45 | |
| Brian Field | Emerald Expositions Events | 55 | |
| W LaFoy | Boston Omaha Corp | 58 | |
| Sally Shankland | Emerald Expositions Events | N/A | |
| Barry McCarthy | Deluxe | 61 | |
Management Performance
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.0878 |
Cardlytics Leadership Team
Elected by the shareholders, the Cardlytics' board of directors comprises two types of representatives: Cardlytics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardlytics. The board's role is to monitor Cardlytics' management team and ensure that shareholders' interests are well served. Cardlytics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardlytics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Evelyne Forester, Chief Officer | ||
| Carson Napps, Chief Officer | ||
| Jared Luskin, Senior Vice President for Growth Verticals | ||
| Jose Singer, Chief Officer | ||
| Alexis DeSieno, Chief Officer | ||
| Karim Temsamani, CEO Director | ||
| James Hart, VP People | ||
| Amit Gupta, CEO Director | ||
| Kirk Esq, Sec | ||
| Peter Davies, Head Operations | ||
| Nick Lynton, Chief Secretary | ||
| Craig Snodgrass, Chief Officer | ||
| Peter Chan, Chief Officer | ||
| Angie Amberg, Head Communications | ||
| Andrew Christiansen, Chief Officer | ||
| Rory Mitchell, Chief Officer |
Cardlytics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardlytics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.35 | ||||
| Return On Asset | -0.0878 | ||||
| Profit Margin | (0.65) % | ||||
| Operating Margin | (0.31) % | ||||
| Current Valuation | 247.96 M | ||||
| Shares Outstanding | 52.5 M | ||||
| Shares Owned By Insiders | 2.70 % | ||||
| Shares Owned By Institutions | 55.23 % | ||||
| Number Of Shares Shorted | 8.57 M | ||||
| Price To Earning | (3.47) X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.